Joaquim Aguirre‐Plans

In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm

Laura Artigas, Mireia Coma, Pedro Matos‐Filipe et al. · PLoS ONE · 2020 · 66 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

GUILDify v2.0: A Tool to Identify Molecular Networks Underlying Human Diseases, Their Comorbidities and Their Druggable Targets

Joaquim Aguirre‐Plans, Janet Piñero, Ferrán Sanz et al. · Journal of Molecular Biology · 2019 · 52 citations · Full text

Life Sciences, Bioinformatics, Systems Biology +16

In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan

Guillem Jorba, Joaquim Aguirre‐Plans, Valentin Junet et al. · PLoS ONE · 2020 · 44 citations · Full text

Life Sciences, Pharmacology, Systems Biology +16

Proximal Pathway Enrichment Analysis for Targeting Comorbid Diseases via Network Endopharmacology

Joaquim Aguirre‐Plans, Janet Piñero, Jörg Menche et al. · Pharmaceuticals · 2018 · 43 citations · Full text

Life Sciences, Bioinformatics, Pharmacology +16

Using collections of structural models to predict changes of binding affinity caused by mutations in protein–protein interactions

Alberto Meseguer, Lluis Dominguez, Patricia Mirela Bota et al. · Protein Science · 2020 · 22 citations · Full text

Life Sciences, Bioinformatics, Biophysics +17